Danh mục
Nạp tiền Tải xuống 0

Tất cả tài liệu

Sắp xếp:
  • Mới nhất
  • Xem nhiều nhất
  • Tải nhiều nhất

HoSAGE: Sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: Study protocol for a cohort trial

HoSAGE: Sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: Study protocol for a cohort trial

15 0 0
7 trang
Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: A phase I dose escalation study

Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: A phase I dose escalation study

11 0 0
8 trang
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: A population-based study (2011-2018)

Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: A population-based study (2011-2018)

18 0 0
10 trang
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

11 0 0
11 trang
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: Results from a multicentre prospective study

Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: Results from a multicentre prospective study

9 0 0
8 trang
Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer

Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer

8 0 0
12 trang
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016

Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016

8 0 0
12 trang
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): A pragmatic phase III randomized controlled trial

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): A pragmatic phase III randomized controlled trial

8 0 0
11 trang
A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer

A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer

18 0 0
5 trang
Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: A meta-analysis

Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: A meta-analysis

7 0 0
9 trang
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: A prospective study in the Swedish AMORIS cohort

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: A prospective study in the Swedish AMORIS cohort

16 0 0
9 trang
Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT

Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT

14 0 0
18 trang
SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low-and favorable intermediate-risk prostate cancer

SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low-and favorable intermediate-risk prostate cancer

5 0 0
10 trang
Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer

9 0 0
7 trang
BioPro-RCMI-1505 trial: Multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

BioPro-RCMI-1505 trial: Multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

8 0 0
6 trang
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castrationsensitive prostate cancer patients with osteoporosis

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castrationsensitive prostate cancer patients with osteoporosis

10 0 0
7 trang
A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy

A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy

11 0 0
11 trang
Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): A randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): A randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors

8 0 0
10 trang